Yüklüyor......

依布替尼通过新型途径克服弥漫大B细胞淋巴瘤细胞耐药机制的研究

OBJECTIVE: To explore the mechanism of ibrutinib on drug resistance diffuse large B-cell lymphoma (DLBCL) cells. METHODS: DLBCL cell line was cultured with mesenchymal stem cells (MSC), and DLBCL cells which migrated and adhered to MSC under microscope was counted. The secretion of CXCL12 by MSC wer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Zhonghua Xue Ye Xue Za Zhi
Yazar: Sotomayor, E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Editorial office of Chinese Journal of Hematology 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7342183/
https://ncbi.nlm.nih.gov/pubmed/29365396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.12.006
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!